Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Glucagon immunoreactivity in plasma from normal and dystrophic mice.

Literature DB >> 6178642

Glucagon immunoreactivity in plasma from normal and dystrophic mice.

B Ahrén, I Lundquist.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 1982 PMID： 6178642 DOI： 10.1007/BF00281302

Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122

× No keyword cloud information.

17 in total

1. Glucagon antibodies and their use for immunoassay for glucagon.

Authors: R H UNGER; A M EISENTRAUT; M S McCALL; S KELLER; H C LANZ; L L MADISON
Journal: Proc Soc Exp Biol Med Date: 1959 Oct-Dec

2. High molecular weight glucagon-like immunoreactivity in plasma.

Authors: G C Weir; S D Knowlton; D B Martin
Journal: J Clin Endocrinol Metab Date: 1975-02 Impact factor: 5.958

Review 3. Physiology and pathophysiology of glucagon.

Authors: R H Unger; L Orci
Journal: Physiol Rev Date: 1976-10 Impact factor: 37.312

4. Production and characterization of an antiserum against pancreatic glucagon.

Authors: H Von Schenck
Journal: Clin Chim Acta Date: 1977-11-01 Impact factor: 3.786

5. Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

Authors: I Valverde; M L Villanueva; I Lozano; J Marco
Journal: J Clin Endocrinol Metab Date: 1974-12 Impact factor: 5.958

6. Hormone-substrate responses to total fasting in lean and obese mice.

Authors: G S Cuendet; E G Loten; D P Cameron; A E Renold; E B Marliss
Journal: Am J Physiol Date: 1975-01

7. The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.

Authors: R L Lavine; N Voyles; P V Perrino; L Recant
Journal: Endocrinology Date: 1975-09 Impact factor: 4.736

8. Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling.

Authors: C Rerup; I Lundquist
Journal: Acta Endocrinol (Copenh) Date: 1966-07

9. Interrelationships between alpha and beta-anomers of glucose affecting both insulin and glucagon secretion in the perfused rat pancreas. II.

Authors: G M Grodsky; R Fanska; I Lundquist
Journal: Endocrinology Date: 1975-09 Impact factor: 4.736

10. Insulin secretion and carbohydrate metabolism in the dystrophic mouse.

Authors: I Lundquist; J B Harris
Journal: Eur J Pharmacol Date: 1979-02-01 Impact factor: 4.432

12 in total

1. Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

Authors: B Akesson; H Mosén; G Panagiotidis; I Lundquist
Journal: Br J Pharmacol Date: 1996-10 Impact factor: 8.739

2. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets.

Authors: A Salehi; M Ekelund; R Henningsson; I Lundquist
Journal: Endocrine Date: 2001-11 Impact factor: 3.633

7. Contribution of adrenergic nerves and the adrenals to 2-deoxy-D-glucose-induced insulin and glucagon secretion in the mouse.

Authors: S Karlsson; B Ahrén
Journal: Int J Pancreatol Date: 1991 Nov-Dec

Glucagon immunoreactivity in plasma from normal and dystrophic mice.

1. Glucagon antibodies and their use for immunoassay for glucagon.

2. High molecular weight glucagon-like immunoreactivity in plasma.

Review 3. Physiology and pathophysiology of glucagon.

4. Production and characterization of an antiserum against pancreatic glucagon.

5. Presence of glucagon immunoreactivity in the globulin fraction of human plasma ("big plasma glucagon").

6. Hormone-substrate responses to total fasting in lean and obese mice.

7. The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.

8. Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling.

9. Interrelationships between alpha and beta-anomers of glucose affecting both insulin and glucagon secretion in the perfused rat pancreas. II.

10. Insulin secretion and carbohydrate metabolism in the dystrophic mouse.

1. Interaction of the islet nitric oxide system with L-arginine-induced secretion of insulin and glucagon in mice.

2. Total parenteral nutrition modulates hormone release by stimulating expression and activity of inducible nitric oxide synthase in rat pancreatic islets.

Review 3. Alpha cell function in health and disease: influence of glucagon-like peptide-1.

4. Influence of nitric oxide modulators on cholinergically stimulated hormone release from mouse islets.

5. Effects of galanin on insulin and glucagon secretion in the rat.

6. Nitric oxide and hydroperoxide affect islet hormone release and Ca(2+) efflux.

7. Contribution of adrenergic nerves and the adrenals to 2-deoxy-D-glucose-induced insulin and glucagon secretion in the mouse.

8. Effects of calcitonin gene-related peptide (CGRP) on islet hormone secretion in the pig.

9. Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice.

10. Effects of helospectin I on insulin and glucagon secretion in the mouse.